Serum concentration of cystatin C and risk of end-stage renal disease in diabetes. - Wikidata - awgldk - TriplyDB

Serum concentration of cystatin C and risk of end-stage renal disease in diabetes.

Serum concentration of cystatin C and risk of end-stage renal disease in diabetes.

http://www.wikidata.org/entity/Q36334563

about

Chronic kidney disease screening methods and its implication for Malaysia: an in depth review Early diabetic nephropathy in type 1 diabetes: new insights Progressive renal decline: the new paradigm of diabetic nephropathy in type 1 diabetes.Filtration markers as predictors of ESRD and mortality in Southwestern American Indians with type 2 diabetes.Urinary Cyclophilin A as a New Marker for Diabetic Nephropathy: A Cross-Sectional Analysis of Diabetes Mellitus Serum Cystatin C, Markers of Chronic Kidney Disease, and Retinopathy in Persons with Diabetes High risk of ESRD in type 1 diabetes: new strategies are needed to retard progressive renal function decline Cystatin C- and Creatinine-Based Estimates of Glomerular Filtration Rate in Dapagliflozin Phase 3 Clinical Trials Update on cystatin C: incorporation into clinical practice.Association between Serum Cystatin C and Diabetic Foot Ulceration in Patients with Type 2 Diabetes: A Cross-Sectional Study.Early diabetic nephropathy: a complication of reduced insulin sensitivity in type 1 diabetes.Early progressive renal decline precedes the onset of microalbuminuria and its progression to macroalbuminuria.Cystatin C as a predictor of mortality and cardiovascular events in a population with chronic kidney disease Serum uric acid and hypertension in adults: a paradoxical relationship in type 1 diabetes.Progressive renal decline as the major feature of diabetic nephropathy in type 1 diabetes.Update on Estimation of Kidney Function in Diabetic Kidney Disease.Novel Biomarkers for Renal Diseases? None for the Moment (but One).Biomarkers of progression in diabetic nephropathy: The past, present and future Cystatin C, chronic kidney disease and retinopathy in adults without diabetes.Risk prediction of major complications in individuals with diabetes: the Atherosclerosis Risk in Communities Study.Evaluation of creatinine-based and cystatin C-based equations for estimation of glomerular filtration rate in type 1 diabetic patients.Kidney Function Can Predict Pregnancy Outcomes.Soluble cMet levels in urine are a significant prognostic biomarker for diabetic nephropathy

P2860

Q26822369-1D5B2C42-5559-4ECA-A794-8ED7645A6010 Q27021632-13D232B7-8C9F-4FE1-AEBE-034F405F39E2 Q35630730-8415D661-26EB-4B38-9134-0170D0AC83C2 Q35797913-E7430884-8366-434A-89A2-7D27EC7A3AF4 Q36207045-AD877C10-FA81-4C3C-A210-32BFC248F751 Q36241451-2BCEF225-7D9E-48BF-A55A-C020BBA9A45B Q36328889-B6CD99EB-D1F2-4412-A572-3618FC096CDE Q36712221-4A6DAC14-92B8-496C-B1B9-6DCE76966326 Q37126287-7EA0E226-7540-40DF-A60B-7EDA67A5D607 Q37271136-0E4E884C-FA42-4E19-B8DF-7CCBAD18ADA8 Q37278013-EB9059F4-416A-4038-ABE9-2FD4EC2F9F99 Q37403180-E7A4DF69-4C37-4F95-889B-39F1AB52E828 Q37616789-7E981334-8F43-4A41-8340-4E435943DA73 Q37707005-706767F3-4D8D-4CDF-B21F-218A3E5E78B7 Q38161868-1A2FEE68-FCED-4F5F-B6C3-7797AED4B74E Q38549960-7FB5D90E-C18F-4E0E-9404-C6C84FC1F124 Q38763898-1E4F7B01-45CA-49C2-9B8F-BA72EDADAAA3 Q39007369-63042385-97E3-4E15-9F32-46BB551BCC4A Q40356301-2747486C-BDD1-4D43-88BD-71052342C205 Q40762736-55E87130-2CEA-4220-B4E3-F10DB5BAB7B3 Q50643798-4D51FFB9-0F93-4EBD-813C-0EA1CCAAABF7 Q54034688-EE455CED-0F04-4DB5-8704-3197252F5770 Q58708114-7343A26D-5B5F-44B1-BD90-F2FD6435ADDD

P2860

Serum concentration of cystatin C and risk of end-stage renal disease in diabetes.

http://www.wikidata.org/entity/Q36334563

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

2012年學術文章

@zh

2012年學術文章

@zh-hant

name

Serum concentration of cystatin C and risk of end-stage renal disease in diabetes.

@ast

Serum concentration of cystatin C and risk of end-stage renal disease in diabetes.

@en

type

label

Serum concentration of cystatin C and risk of end-stage renal disease in diabetes.

@ast

Serum concentration of cystatin C and risk of end-stage renal disease in diabetes.

@en

prefLabel

Serum concentration of cystatin C and risk of end-stage renal disease in diabetes.

@ast

Serum concentration of cystatin C and risk of end-stage renal disease in diabetes.

@en

P1433

Q36334563-F97AAA4F-7DCD-4AF4-856C-5A9EF324721D

P1476

Q36334563-B2597B80-3E06-44B9-BCA6-8C19AA5F7D80

P2093

Q36334563-0933D7BC-28ED-42D1-A31F-562D25A0C932

Q36334563-0FD276D1-0AA5-4628-A449-4027C61A8703

Q36334563-12D8889E-3AE8-43B5-AEF8-0482CEC818A2

Q36334563-1AF7B454-8E0D-41A4-8E2B-A76FA9A562E6

Q36334563-7615FD7D-0B08-4800-B755-86E364836CDB

Q36334563-AF49F99F-172A-48DB-B921-FBEE9B087BD0

Q36334563-C7D0661A-F2AE-48AE-8249-60822974B0A0

Q36334563-FD70BC01-9A6E-4536-97F9-034BEDDD6389

P2860

Q36334563-01D2152B-0B82-46B0-B0BC-FE3F245B5642

Q36334563-02C315D8-99F2-4ADB-92CA-128A3CE9F3EB

Q36334563-04608D00-FECE-4491-8B0F-010AAFF76028

Q36334563-0A98FBD9-99BD-4F3F-BA18-D698D3FC7888

Q36334563-2A9DF54D-7E1B-4795-BE9D-9AE15226B706

Q36334563-3420E22D-F82E-4B4F-BB5C-DF9A851EDBB8

Q36334563-35989706-49B6-476B-A100-BD7B0B38E790

Q36334563-445B9A6E-37F5-45D4-8BEB-4326DD9D6839

Q36334563-6B72C360-6D59-4192-B5BA-986BF95C8E82

Q36334563-76BDAB5D-5BDA-4DD4-AF51-BE897EFDC809

P304

Q36334563-35295723-3C4F-419B-9B45-64B6B23385DF

P31

Q36334563-F4D9FA51-6C7D-43F6-9B50-C47B0598F0FC

P356

Q36334563-A334CB73-630F-4BF2-99DF-BE6FA737AB5F

P407

Q36334563-37F9D88E-0E54-45C9-BDE6-D9A2C3356C3F

P433

Q36334563-0720D29D-9F52-4A12-B450-352624156334

P478

Q36334563-ADAC69AA-FD2D-4202-A422-46CF637A3CC2

P50

Q36334563-13748586-1BBA-4792-85CD-F12EFABFB914

Q36334563-5E2A95AE-8529-4322-82D3-398778AA4F7F

Q36334563-7CFDD0F8-0CA8-4DA9-9FE6-B28FE8503E08

P577

Q36334563-3E9E8436-E3C3-4731-A183-EEB188FB2E46

P5875

Q36334563-FDA75DDD-8BFB-4307-953B-00DA42B121CC

P698

Q36334563-58557F40-4E19-428C-9B81-E54D543DA25E

P932

Q36334563-065323AF-A6A9-4550-BFB0-116A116ED0E9

P356

P1433

P1476

Serum concentration of cystatin C and risk of end-stage renal disease in diabetes.

@en

P2093

Adam M Smiles

http://www.w3.org/2001/XMLSchema#string

Andrzej S Krolewski

http://www.w3.org/2001/XMLSchema#string

James H Warram

http://www.w3.org/2001/XMLSchema#string

Jan Skupien

http://www.w3.org/2001/XMLSchema#string

John H Eckfeldt

http://www.w3.org/2001/XMLSchema#string

Lesley A Inker

http://www.w3.org/2001/XMLSchema#string

Robert Stanton

http://www.w3.org/2001/XMLSchema#string

Valma Harjutsalo

http://www.w3.org/2001/XMLSchema#string

P2860

A new equation to estimate glomerular filtration rate

Estimating GFR using serum cystatin C alone and in combination with serum creatinine: a pooled analysis of 3,418 individuals with CKD

Cystatin C and the risk of death and cardiovascular events among elderly persons

Can cystatin C replace creatinine to estimate glomerular filtration rate? A literature review

K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification

Serum cystatin C as an endogenous marker of the renal function--a review.

Cystatin C identifies chronic kidney disease patients at higher risk for complications.

Assessing kidney function--measured and estimated glomerular filtration rate.

Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate.

Measured GFR as a confirmatory test for estimated GFR.

P304

2311-2316

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2337/DC11-2220

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

35

http://www.w3.org/2001/XMLSchema#string

P50

Per-Henrik Groop

P577

2012-07-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

230592912

http://www.w3.org/2001/XMLSchema#string

P698

22851596

http://www.w3.org/2001/XMLSchema#string

P932

3476893

http://www.w3.org/2001/XMLSchema#string